ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 64 out of 247

$473K Total Retail Price of All Prescriptions

Rank: 60 out of 247

426 Patients Receiving at Least One Drug in Part D
75% Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Mexico
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 333 257 81 1 2
LEVOTHYROXINE SODIUM 277 233 71 2 1
GABAPENTIN 240 173 70 3 11
FUROSEMIDE 235 212 50 4 9
OMEPRAZOLE 200 150 62 5 5
METFORMIN HCL 188 170 50 6 6
ATORVASTATIN CALCIUM 178 162 46 7 8
RANITIDINE HCL 161 133 39 8 35
AMLODIPINE BESYLATE 159 140 39 9 4
METOPROLOL TARTRATE 146 141* 31 10 13
SIMVASTATIN 142 114 41 11 3
PRAVASTATIN SODIUM 136 104 40 12 27
WARFARIN SODIUM 136 108 31 12 16
TAMSULOSIN HCL 135 113 28 14 21
METOPROLOL SUCCINATE 131 131 33 15 14
HYDROCODONE-ACETAMINOPHEN 108 81 44 S3 16 7
POTASSIUM CHLORIDE 105 93 28 17 17
HYDROCHLOROTHIAZIDE 104 89 29 18 10
CYMBALTA 92 87* 14 19 60
CLOPIDOGREL 91 86* 25 20 29
ALPRAZOLAM 86 75 21 B 21 26
SERTRALINE HCL 77 72* 17 22 24
FLUOXETINE HCL 75 63 13 23 49
PROAIR HFA 74 33 40 24 41
ADVAIR DISKUS 74 69* 17 24 58
NAMENDA 70 70 12 26 43
ZOLPIDEM TARTRATE 69 43 26 27 23
LOSARTAN POTASSIUM 69 64* 22 27 12
DONEPEZIL HCL 68 63* 13 29 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 57* 36 30 110
ALLOPURINOL 57 52* 16 31 30
CITALOPRAM HBR 54 49* 13 32 22
TRAMADOL HCL 53 26 30 33 28
CARVEDILOL 53 34 15 33 31
GLIPIZIDE 53 48* 13 33 39
MONTELUKAST SODIUM 52 47* 12 36 57
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.